Authors
Loading...
Review highlights advances in targeted radiopharmaceuticals and personalized dosimetry in diverse malignancies, suggesting transformative potential for precision cancer care.
Al‐Ibraheem et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: